INDV · Indivior Pharmaceuticals, Inc. · Documents

$34.77 +0.90 (+2.66%)

Market Cap

$4.00B

118.01M

Volume · Oct 20 1.92M Avg daily vol (3M) 2.3M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2025-02-27	—
6-K	—	2025-02-27	—
6-K	—	2025-02-25	—
6-K	—	2025-02-24	—
6-K	—	2025-02-20	2024-12-31
6-K/A	—	2025-02-20	2024-12-31
6-K	—	2025-02-12	—
6-K	—	2025-02-04	—
6-K	—	2025-02-04	—
6-K	—	2025-02-04	—
6-K	—	2025-02-03	—
6-K	—	2025-02-03	—
6-K	—	2025-01-28	—
6-K	—	2025-01-28	—
6-K	—	2025-01-28	—
6-K	—	2025-01-27	—
6-K	—	2025-01-21	—
6-K	—	2025-01-14	—
6-K	—	2025-01-10	—
6-K	—	2025-01-07	2024-01-07
6-K	—	2025-01-07	2024-01-07
6-K	—	2025-01-02	—
6-K	—	2024-12-31	—
6-K	—	2024-12-31	—
6-K	—	2024-12-26	—
6-K	—	2024-12-23	—
6-K	—	2024-12-17	—
6-K	—	2024-12-17	—
6-K	—	2024-12-10	—
6-K	—	2024-12-03	—
6-K	—	2024-12-02	—
6-K	—	2024-11-26	—
6-K	—	2024-11-22	—
6-K	—	2024-11-19	—
6-K	—	2024-11-18	—
6-K	—	2024-11-15	—
6-K	—	2024-11-12	—
6-K	—	2024-11-12	—
6-K	—	2024-11-08	—
6-K	—	2024-11-08	—
6-K	—	2024-11-08	—
6-K	—	2024-11-05	—
6-K	—	2024-11-05	—
6-K	—	2024-11-01	—
6-K	—	2024-10-29	—
6-K	—	2024-10-24	2024-09-30
6-K	—	2024-10-22	—
6-K	—	2024-10-15	—
6-K	—	2024-10-15	—
6-K	—	2024-10-10	—

Showing 51–100 of 386 filings

Key facts CIK 1625297 CUSIP 45579U109 13F (30d) 28 filings 28 filers Visit website Investor relations